AAV Purification Affinity Resin Wash Steps
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying adeno-associated virus (AAV) lack efficiency in removing host cell materials, leading to impurities in the final product, which can affect its safety and efficacy for clinical use.
Innovation Solution
A method involving multiple wash steps with specific buffers, including those containing organic solvents and detergents, is used to purify AAV by binding to an affinity resin, followed by elution, which effectively removes host cell proteins and DNA, enhancing the purity of the AAV product.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional AAV purification methods are used, then the purification process is simple, but host cell materials remain in the final product leading to impurities
Solution Approach 1:
The purification process is divided into multiple sequential wash steps, each targeting specific types of host cell contaminants. The first wash removes loosely bound proteins, the second wash removes additional proteins and proteasomes, and the third wash removes cell debris and receptors, with each step building upon the previous to achieve progressive purification
Solution Approach 2:
Different wash buffers with varying compositions are applied at different stages. The buffers contain different concentrations of organic solvents, detergents, and other agents that selectively remove different types of contaminants while preserving AAV infectivity, demonstrating parameter changes in chemical composition to achieve selective purification
2Manufacturing precision
If multiple wash steps with organic solvents and detergents are applied, then host cell materials are effectively removed, but the process complexity and time increase
Solution Approach 1:
The method performs preliminary removal of host cell materials during the wash steps before final elution. By pre-removing proteins, proteasomes, cell debris, and receptors during sequential washes, the process prevents contamination of the final eluate without requiring additional post-elution purification steps
Solution Approach 2:
The purification process maintains continuous useful action through sequential wash steps that progressively remove different classes of contaminants. Each wash step builds upon the previous, maintaining momentum in the purification process rather than requiring restarts or intermediate processing steps
3Manufacturing precision
If stringent purification conditions are applied, then purity increases, but virus infectivity and potency may be compromised
Solution Approach 1:
The elution conditions are carefully optimized to achieve high purity while preserving infectivity. The method uses specific pH ranges and buffer compositions that are stringent enough to remove contaminants but gentle enough to maintain viral particle integrity and biological activity
Solution Approach 2:
The method replicates physiological conditions during elution to ensure proper folding and activity of the purified AAV. By using buffers that mimic cellular environments, the process maintains viral protein structures and functional properties that would be lost under more extreme purification conditions
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high purity of AAV with reduced host cell impurities, maintaining the virus's infectivity and potency, thereby improving the safety and effectiveness of AAV-based gene therapy products.
Implementation Method 1
loading an AAV containing solution onto an affinity resin targeted against AAV under conductions that allow binding between the AAV in the solution and the affinity resin
Implementation Method 2
contacting the AAV containing solution with an anion exchanger and eluting the AAV containing solution from the anion exchanger
Data Source
AI summary
Provided herein are methods of producing an adeno-associated virus (AAV) product and methods of purifying adeno-associated virus. AAV is loaded onto an affinity resin, wash steps are undertaken, and AAV is eluted from the affinity resin. Various buffers are disclosed for use in the wash steps and elution.